Cotec Healthcare IPO Description – Cotec Healthcare operates as a fast-growing pharmaceutical Contract Development and Manufacturing Organization (CDMO) in India, offering end-to-end services across formulation development, loan licensing, and commercial manufacturing of off-patent and complex generic drugs. It is the second-largest player among assessed peers in terms of dosage-form capabilities, with expertise across 24 distinct formulation types including injectables, tablets, capsules, syrups, ointments, eye drops, ampoules, vials, and infusions.
The company primarily caters to institutional and private pharmaceutical clients and has built long-standing relationships through consistent product development and commercialization capabilities. Its portfolio spans both acute and chronic therapeutic segments such as anti-diabetics, antibiotics, cardiovascular, dermatology, CNS, women’s health, and clinical nutrition products. Its manufacturing operations are based in Roorkee, Uttarakhand, where it operates three dedicated manufacturing units spread across 21,871.71 square meters with an installed capacity of 4,051.38 million units as of March 2025. As of 31 August 2025, the company has an employee base of 419.
Promoters of Cotec Healthcare – Harsh Tiwari and Vandana Tiwari
Cotec Healthcare IPO Details
| Cotec Healthcare IPO Dates | Coming soon |
| Cotec Healthcare Issue Price | Coming soon |
| Fresh Issue | INR 295 crore |
| Offer For Sale | 60,00,000 shares |
| Total IPO Size | Coming soon |
| Minimum Bid (Lot Size) | Coming soon |
| Pre-issue Shares | 11,42,06,346 shares |
| Face Value | INR 5 per share |
| Listing On | NSE, BSE |
Cotec Healthcare IPO Allocation in Different Categories
Cotec Healthcare Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Revenue | 82.42 | 138.00 | 192.24 |
| Expenses | 75.72 | 124.42 | 166.04 |
| Net Income | 5.03 | 10.46 | 20.00 |
| Margin (%) | 6.10 | 7.58 | 10.40 |
Cotec Healthcare Offer News
Cotec Healthcare Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 (Pre-Issue) | FY 2026* (Post-Issue) | |
| EPS | 0.44 | 0.92 | 1.75 | – |
| PE Ratio | – | – | – | – |
| Price/Sales Ratio | – | – | – | – |
| Price/Book Ratio | – | – | – | – |
| Current Ratio | – | – | – | – |
| FY 2023 | FY 2024 | FY 2025 | |
| RONW (%) | 17.76 | 26.89 | 33.91 |
| NAV | 2.48 | 3.41 | 5.16 |
| ROCE (%) | 21.49 | 33.31 | 36.43 |
| EBITDA (%) | 11.54 | 12.41 | 16.36 |
| Debt/Equity | 0.40 | 0.40 | 0.44 |
Evaluate the quality of an IPO using these essential investing ratios to make an informed decision.
Cotec Healthcare IPO Anchor Investors
Cotec Healthcare raises () from anchor investors. Cotec Healthcare Anchor bid date is ().
| Bid Date | Coming soon |
| Shares Offered | Coming soon |
| Anchor Portion (INR Cr.) | Coming soon |
| Anchor lock-in period end date for 50% shares (30 Days) | Coming soon |
| Anchor lock-in period end date for remaining shares (90 Days) | Coming soon |
Cotec Healthcare IPO GMP Today (Daily Trend)
Cotec Healthcare Offer Objectives
The company proposes to utilize net proceeds from the issue towards the following objects:
- Funding capital expenditure requirements for setting up a new project to enhance existing manufacturing capacities and manufacture new products – INR 226.25 crore
- General Corporate Purposes
Cotec Healthcare IPO Subscription – Live Updates
Coming soon
() shares allotted to anchor investors are not included in these calculations.
Cotec Healthcare – Comparison With Listed Peers
Cotec Healthcare IPO Allotment Status
You can check Cotec Healthcare IPO allotment status on Kfin Technologies’ website. Click on this link to get the allotment status. Often not getting IPO allotment? Learn how to improve your IPO allotment chances.
Cotec Healthcare IPO Dates & Listing Performance
| IPO Opening Date | Coming soon |
| IPO Closing Date | Coming soon |
| Finalization of Basis of Allotment | Coming soon |
| Initiation of refunds | Coming soon |
| Transfer of shares to demat accounts | Coming soon |
| Cotec Healthcare IPO Listing Date | Coming soon |
| Opening Price on NSE | Coming soon |
| Closing Price on NSE | Coming soon |
Cotec Healthcare IPO Reviews – Subscribe or Avoid?
Angel One –
Anand Rathi –
Axis Capital –
Antique Stock Broking –
Arihant Capital –
Ashika Research –
Asit C Mehta –
BP Wealth –
Capital Market –
Canara Bank Securities –
Choice Broking –
Dalal & Broacha –
Elite Wealth –
GCL Broking –
Geojit –
GEPL Capital –
Hem Securities –
ICICIdirect –
Investmentz –
Jainam Broking –
DR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Nirmal Bang –
Reliance Securities –
SBI Securities –
Samco Securities –
SMC Global –
Swastika Investmart –
Ventura Securities –
Cotec Healthcare IPO Lead Manager
PANTOMATH CAPITAL ADVISORS PRIVATE LIMITED
Pantomath Nucleus House, Saki Vihar Road,
Andheri East, Mumbai – 400 072 Maharashtra, India
Phone: 18008898711
Email: [email protected]
Website: www.pantomathgroup.com
Cotec Healthcare Offer Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com
COTEC HEALTHCARE LIMITED
Kishanpur, Bhagwanpur, NH-74,
Roorkee Dehradun Highway, Bhagwanpur,
Haridwar, Roorkee – 247 661, Uttarakhand
Phone: +91 133 223 2248
Email: [email protected]
Website: www.cotec.in
IPO Resources
How many shares in Cotec Healthcare IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply in Cotec Healthcare Public Offer?
What is Cotec Healthcare IPO GMP today?
Cotec Healthcare IPO GMP today is INR NA per share.
What is Cotec Healthcare Subject to Sauda rate today?
Cotec Healthcare Subject to Sauda rate today is INR NA per application.
Krishna comes from a family of investors and financial analysts, She learnt wading through regulatory filings pretty early in her career. She has several years of experience in financial and industry analysis under her belt. At IPO Central, Krishna plays twin roles of Contributor and Head of research desk.
